Is bone mineral density monitoring necessary in urolithiasis patients?

The majority of patients with renal stone disease have a metabolic disorder that could result in decreased bone mass. Through careful assessment of patient-specific risk factors, it is possible to determine which patients are at greatest risk for BMD loss. By regularly monitoring these patients, physicians can help to minimize the risk of bone fractures.